EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

New Onset of Primary Membranous Nephropathy After COVID ‐19 mRNA Vaccination in Affected Sjögren's Syndrome

Chia-Wei Tseng iD, Jing-Huan Liao, Tai-Kuang Chao, Shun-Neng Hsu

Nephrology · 2025

DOI: 10.1111/nep.70048 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephrology, 2025. Verfasst von Chia-Wei Tseng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, Sjogren's Syndrome, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global administration of mRNA vaccines in response to the coronavirus disease 2019 (COVID‐19) pandemic has been crucial in mitigating the spread of the virus. While these vaccines are generally safe and effective, there have been occasional reports of rare adverse effects, including new‐onset nephropathies. Primary Sjögren's syndrome (pSS), an autoimmune disorder primarily affecting the exocrine glands, can also present with renal involvement, most commonly as tubulointerstitial nephritis (TIN). A 52‐year‐old female with a history of pSS developed shortness of breath, generalised edema, and oliguria 1 month after receiving her fourth dose of the COVID‐19 mRNA vaccine. Initial evaluation revealed bilateral pleural effusion on chest X‐ray. Laboratory evaluations revealed rapidly progressive glomerulonephritis (RPGN) and nephrotic syndrome. Renal biopsy findings showed mesangial expansion, focal crescent formation, pronounced tubulointerstitial nephritis, and positive staining for anti‐phospholipase A2 receptor (PLA2R). The temporal association, coupled with renal biopsy findings, strongly suggested a vaccine‐related trigger, and the diagnosis of new‐onset primary membranous nephropathy (MN) following COVID‐19 mRNA vaccination was made. The patient was treated with haemodialysis, plasma exchange, corticosteroid pulse therapy, and immunosuppressive agents, resulting in complete remission of proteinuria within 3 months. This case underscores the potential for COVID‐19 mRNA vaccines to precipitate primary MN in patients with pre‐existing familial autoimmune conditions such as pSS. It also emphasises the importance of recognising vaccine‐related renal complications in autoimmune patients and the necessity for close monitoring and prompt intervention to prevent serious complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranousSjogren's SyndromeCOVID-19COVID-19 VaccinesHumansFemaleMiddle AgedSARS-CoV-2Immunosuppressive AgentsTreatment Outcome

Stichwörter der Autor:innen

COVID‐19Sjögren's syndromeacute kidney injurymRNA vaccinemembranous nephropathynephrotic syndrome

Substanzen

COVID-19 VaccinesImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Institute of Pathology and Parasitology, National Defense Medical Center, Taipei, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

ORCID-Profile: Chia-Wei Tseng

Zitieren

APA

Tseng, C. W., Liao, J. H., Chao, T. K., & Hsu, S. N. (2025). New Onset of Primary Membranous Nephropathy After COVID ‐19 mRNA Vaccination in Affected Sjögren's Syndrome. Nephrology. https://doi.org/10.1111/nep.70048

Vancouver

Tseng CW, Liao JH, Chao TK, Hsu SN. New Onset of Primary Membranous Nephropathy After COVID ‐19 mRNA Vaccination in Affected Sjögren's Syndrome. Nephrology. 2025. doi:10.1111/nep.70048

BibTeX
@article{Tseng2025,
  author = {Tseng, Chia-Wei and Liao, Jing-Huan and Chao, Tai-Kuang and Hsu, Shun-Neng},
  title = {New Onset of Primary Membranous Nephropathy After COVID ‐19 mRNA Vaccination in Affected Sjögren's Syndrome},
  journal = {Nephrology},
  year = {2025},
  doi = {10.1111/nep.70048}
}
Kostenlos starten →